Danos Olivier

Chief Scientific Officer at RGNX

Sold, on record
$1.4M
Dollars the filings state
Form 4 sales
2
Latest Apr 15, 2019
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • RGNXREGENXBIO Inc.Chief Scientific Officer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale RGNXUnusual
    Oct 8, 2018 2018

    Sold 20,000 shares at $63.80 ($1.3M)

    Danos Olivier, Chief Scientific Officer

    Sold 100% of holdings ($1.3M position)0 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale RGNXPlan not stated
    Apr 15, 2019 +189 days

    Sold 2,000 shares at $52.66 ($105k)

    Danos Olivier, Chief Scientific Officer

    Sold 23.5% of holdings ($448k position)6,500 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Danos Olivier
Source
Apr 15, 2019Apr 17, 2019RGNXChief Scientific OfficerForm 4 sale2,000$105k23.5%Plan not statedSEC
Oct 8, 2018Oct 10, 2018RGNXChief Scientific OfficerForm 4 sale20,000$1.3M100.0%UnusualSEC